Psychopharmacology and Mental Health

Psychopharmacology and Mental Health

Psychotropic drugs are prescribed to a patient after diagnosis to help diminish the positive and negative symptoms and hopefully improve their quality of life. To further complicate the condition, psychosis is typically comorbid with schizophrenia spectrum disorders, mood and substance use disorders, and many developmental, acquired, and degenerative neurologic and medical conditions (Arciniegas, 2015). Before describing the different sections of the brain that are dysregulated in patients who are afflicted with psychosis, common neurobiological factors in this spectrum of patients will be addressed in order to better understand how antipsychotic drugs can affect an individual’s unique neurobiology. Finally, common neurotransmitters, which are found in deficit or excess, will be examined along with the systems they affect.


Psychosis, along with various other serious mental health issues, is usually diagnosed by using both informal and structured clinical assessments for the presence of positive and/or negative symptoms that are clearly defined common features of psychosis (Arciniegas, 2015). There are many observable behaviors and neurobiological factors clinicians must consider before properly diagnosing and treating someone with a mental health problem. An example of a clinical assessment used to diagnose someone with psychosis is the use of biomarkers (Venigalla, 2017). This is a fairly new approach in diagnosing mental disorders and can help physicians prescribe psychotropic medication(s) that better match the individual’s unique chemical imbalances.

A biomarker is defined as a characteristic that is objectively measured and evaluated as an indicator of normal biologic processes, pathologic processes or biological responses to a therapeutic intervention (Venigalla, 2017). In other words, a biomarker can be a gene or a group of genes, proteins or other biomolecules (Venigalla, 2017).  It is important to note that the development of psychosis is the result from both gene and environment interaction. For example, Schizophrenia is a neurodevelopmental disorder that results from the abnormal development of the prefrontal cortex and hippocampus (Meyer, 2019). The first line of treatment for schizophrenia is usually to reactivate the homeostatic nature of the patient’s dopamine system (Meyer, 2019). Unfortunately, the persistent disconnection between the anatomical and pharmacological aspects of the disorder is still unknown.


Share this:

About the Author

Avatar photo

Christy and Brigitte LewisChristy Lewis holds a Master’s Degree in Social Work from the University of Texas at Arlington and a Doctorate in Clinical Psychology from The Professional School of Psychology.. She is a Licensed Clinical Social Worker (LCSW) and has counseled for a combined 17 years in several clinical and medical settings and has offered career/life coaching for an additional 10 years. Christy is also Board Certified in Biofeedback and Neurofeedback through BCIA, the Biofeedback Certification International Alliance organization.Brigitte graduated in August 2020 from Baylor University in Waco, Texas with a Bachelor of Science degree in Neuroscience. She is currently working toward her BCN (Board Certification in Neurofeedback) certification. Brigitte currently works at the Biofeedback, Education, & Training Center in Plano, Texas as a Sleep/Health Coach and Clinical Intake Coordinator. Sleep/Health Coaching includes providing new clients with educational information regarding behavioral changes and sleep hygiene to help improve overall perceived sleep quality. In the future, Brigitte plans to attend graduate school to study Clinical Psychology with an emphasis on sleep quality and how it affects overall health.

View all posts by Christy and Brigitte Lewis

Leave a Reply